Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites
Open accessPublished version of a preprint
Abstract
Background: Diabetic kidney disease (DKD) and diabetic retinopathy (DR) are major diabetic microvascular complications, contributing significantly to morbidity, disability, and mortality worldwide. The kidney and the eye, having similar microvascular structures and physiological and pathogenic features, may experience similar metabolic changes in diabetes. Objective: This study aimed to use machine learning (ML) methods integrated with metabolic data to identify biomarkers associated with DKD and DR in a multiethnic Asian population with diabetes, as well as to improve the performance of DKD and DR detection models beyond traditional risk factors. Methods: We used ML algorithms (logistic regression [LR] with Least Absolute Shrinkage and Selection Operator and gradient-boosting decision tree) to analyze 2772 adults with diabetes from the Singapore Epidemiology of Eye Diseases study, a population-based cross-sectional study conducted in Singapore (2004-2011). From 220 circulating metabolites and 19 risk factors, we selected the most important variables associated with DKD (defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2) and DR (defined as an Early Treatment Diabetic Retinopathy Study severity level ≥20). DKD and DR detection models were developed based on the variable selection results and externally validated on a sample of 5843 participants with diabetes from the UK biobank (2007-2010). Machine-learned model performance (area under the receiver operating characteristic curve [AUC] with 95% CI, sensitivity, and specificity) was compared to that of traditional LR adjusted for age, sex, diabetes duration, hemoglobin A1c, systolic blood pressure, and BMI. Results: Singapore Epidemiology of Eye Diseases participants had a median age of 61.7 (IQR 53.5-69.4) years, with 49.1% (1361/2772) being women, 20.2% (555/2753) having DKD, and 25.4% (685/2693) having DR. UK biobank participants had a median age of 61.0 (IQR 55.0-65.0) years, with 35.8% (2090/5843) being women, 6.7% (374/5570) having DKD, and 6.1% (355/5843) having DR. The ML algorithms identified diabetes duration, insulin usage, age, and tyrosine as the most important factors of both DKD and DR. DKD was additionally associated with cardiovascular disease history, antihypertensive medication use, and 3 metabolites (lactate, citrate, and cholesterol esters to total lipids ratio in intermediate-density lipoprotein), while DR was additionally associated with hemoglobin A1c, blood glucose, pulse pressure, and alanine. Machine-learned models for DKD and DR detection outperformed traditional LR models in both internal (AUC 0.838 vs 0.743 for DKD and 0.790 vs 0.764 for DR) and external validation (AUC 0.791 vs 0.691 for DKD and 0.778 vs 0.760 for DR). Conclusions: This study highlighted diabetes duration, insulin usage, age, and circulating tyrosine as important factors in detecting DKD and DR. The integration of ML with biomedical big data enables biomarker discovery and improves disease detection beyond traditional risk factors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
He et al. demonstrated that incorporating metabolic features into traditional clinical models improved the prediction of both DR and DN, yielding higher AUCs in both internal and external validation.
“He et al. [102] demonstrated that incorporating metabolic features into traditional clinical models improved the prediction of both DR and DN, yielding higher AUCs in both internal (0.838 versus 0.743 for DN; 0.790 versus 0.764 for DR) and external validation (0.791 versus 0.691 for DN; 0.778 versus 0.760 for DR).”
From Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics (2026) · cites this paper as [102]
The Results, Model Development and Validation (page unavailable), report all four AUC comparisons exactly as cited for diabetic kidney disease (DKD) and diabetic retinopathy (DR). However, they compare machine-learning models using selected risk factors and metabolites with traditional risk-factor logistic regression; they do not isolate the improvement due to adding metabolites to the same clinical model. The paper reports DKD, rather than specifically diabetic nephropathy (DN). (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 40 · Cited by 29
Research works printed but not linked: 33
- [1]Sun H Saeedi P Karuranga S Pinkepank M Ogurtsova K Duncan BB Stein C Basit A Chan JCN Mbanya JC Pavkov ME Ramachandaran A Wild SH James S Herman WH Zhang P Bommer C Kuo S Boyko EJ Magliano DJ IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 Diabetes Res Clin Pract 2022 183 109119 10.1016/j.diabres.2021.109119 34879977 S0168-8227(21)00478-2 34879977 PMC11057359 · DOI · Paper page
- [2]Sabanayagam C Chee ML Banu R Cheng CY Lim SC Tai ES Coffman T Wong TY Association of diabetic retinopathy and diabetic kidney disease with all-cause and cardiovascular mortality in a multiethnic Asian population JAMA Netw Open 2019 2 3 e191540 10.1001/jamanetworkopen.2019.1540 30924904 2729482 30924904 PMC6450319 · DOI
- [3]de Boer IH Rue TC Hall YN Heagerty PJ Weiss NS Himmelfarb J Temporal trends in the prevalence of diabetic kidney disease in the United States JAMA 2011 305 24 2532 2539 10.1001/jama.2011.861 21693741 305/24/2532 21693741 PMC3731378 · DOI · Paper page
- [4]Yau JWY Rogers SL Kawasaki R Lamoureux EL Kowalski JW Bek T Chen SJ Dekker JM Fletcher A Grauslund J Haffner S Hamman RF Ikram MK Kayama T Klein BEK Klein R Krishnaiah S Mayurasakorn K O'Hare JP Orchard TJ Porta M Rema M Roy MS Sharma T Shaw J Taylor H Tielsch JM Varma R Wang JJ Wang N West S Xu L Yasuda M Zhang X Mitchell P Wong TY Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 2012 35 3 556 564 10.2337/dc11-1909 22301125 dc11-1909 22301125 PMC3322721 · DOI · Paper page
- [5]Valencia WM Florez H How to prevent the microvascular complications of type 2 diabetes beyond glucose control BMJ 2017 356 i6505 10.1136/bmj.i6505 28096078 28096078 · DOI
- [6]Eid S Sas KM Abcouwer SF Feldman EL Gardner TW Pennathur S Fort PE New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism Diabetologia 2019 62 9 1539 1549 10.1007/s00125-019-4959-1 31346658 10.1007/s00125-019-4959-1 31346658 PMC6679814 · DOI
- [7]Wu T Qiao S Shi C Wang S Ji G Metabolomics window into diabetic complications J Diabetes Investig 2018 9 2 244 255 10.1111/jdi.12723 28779528 PMC5835462 28779528 · DOI
- [9]Ahola-Olli AV Mustelin L Kalimeri M Kettunen J Jokelainen J Auvinen J Puukka K Havulinna AS Lehtimäki T Kähönen M Juonala M Keinänen-Kiukaanniemi S Salomaa V Perola M Järvelin MR Ala-Korpela M Raitakari O Würtz P Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four finnish cohorts Diabetologia 2019 62 12 2298 2309 10.1007/s00125-019-05001-w 31584131 10.1007/s00125-019-05001-w 31584131 PMC6861432 · DOI
- [10]Quek DQY He F Sultana R Banu R Chee ML Nusinovici S Thakur S Qian C Cheng CY Wong TY Sabanayagam C Novel serum and urinary metabolites associated with diabetic retinopathy in three Asian cohorts Metabolites 2021 11 9 614 10.3390/metabo11090614 34564429 metabo11090614 34564429 PMC8467425 · DOI
- [11]Wong CW Wong TY Cheng CY Sabanayagam C Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways Kidney Int 2014 85 6 1290 1302 10.1038/ki.2013.491 24336029 S0085-2538(15)56362-X 24336029 · DOI · Paper page
- [12]Welsh P Rankin N Li Q Mark PB Würtz P Ala-Korpela M Marre M Poulter N Hamet P Chalmers J Woodward M Sattar N Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial Diabetologia 2018 61 7 1581 1591 10.1007/s00125-018-4619-x 29728717 10.1007/s00125-018-4619-x 29728717 PMC6445481 · DOI
- [13]Colhoun HM Marcovecchio ML Biomarkers of diabetic kidney disease Diabetologia 2018 61 5 996 1011 10.1007/s00125-018-4567-5 29520581 10.1007/s00125-018-4567-5 29520581 PMC6448994 · DOI
- [14]Hastie T Qian J Tay K An introduction to glmnet CRAN R Repositary 2021 New York, NY Springer 1 14
- [16]Sudlow C Gallacher J Allen N Beral V Burton P Danesh J Downey P Elliott P Green J Landray M Liu B Matthews P Ong G Pell J Silman A Young A Sprosen T Peakman T Collins R UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age PLoS Med 2015 12 3 e1001779 10.1371/journal.pmed.1001779 25826379 PMEDICINE-D-12-02351 25826379 PMC4380465 · DOI · Paper page
- [17]Fang XL Chong CCY Thakur S Da Soh Z Teo ZL Majithia S Lim ZW Rim TH Sabanayagam C Wong TY Cheng CY Tham YC Ethnic differences in the incidence of pterygium in a multi-ethnic Asian population: the Singapore epidemiology of eye diseases study Sci Rep 2021 11 1 501 10.1038/s41598-020-79920-9 33436813 10.1038/s41598-020-79920-9 33436813 PMC7804407 · DOI
- [18]Levey AS Stevens LA Schmid CH Zhang YC Castro III AF Feldman HI Kusek JW Eggers P van Lente F Greene T Coresh J A new equation to estimate glomerular filtration rate Ann Intern Med 2009 150 9 604 612 10.7326/0003-4819-150-9-200905050-00006 19414839 150/9/604 19414839 PMC2763564 · DOI · Paper page
- [19]Early Treatment Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House Classification. ETDRS report number 10 Ophthalmology 1991 98 5 Suppl 786 806 2062513 S0161-6420(13)38012-9 2062513
- [20]DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988 44 3 837 845 10.2307/2531595 3203132 · DOI · Paper page
- [21]Yamamoto M Fujihara K Ishizawa M Osawa T Kaneko M Ishiguro H Matsubayashi Y Seida H Yamanaka N Tanaka S Kodama S Hasebe H Sone H Pulse pressure is a stronger predictor than systolic blood pressure for severe eye diseases in diabetes mellitus J Am Heart Assoc 2019 8 8 e010627 10.1161/JAHA.118.010627 30971163 30971163 PMC6507184 · DOI
- [22]Cohen RM Lindsell CJ When the blood glucose and the HbA1c don't match: turning uncertainty into opportunity Diabetes Care 2012 35 12 2421 2423 10.2337/dc12-1479 23173128 35/12/2421 23173128 PMC3507598 · DOI
- [23]Wong TY Cheung N Tay WT Wang JJ Aung T Saw SM Lim SC Tai ES Mitchell P Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study Ophthalmology 2008 115 11 1869 1875 10.1016/j.ophtha.2008.05.014 18584872 S0161-6420(08)00452-1 18584872 · DOI
- [24]Bots SH Peters SAE Woodward M Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010 BMJ Glob Health 2017 2 2 e000298 10.1136/bmjgh-2017-000298 28589033 bmjgh-2017-000298 PMC5435266 28589033 · DOI
- [25]Fernstrom JD Branched-chain amino acids and brain function J Nutr 2005 135 6 Suppl 1539S 1546S 10.1093/jn/135.6.1539S 15930466 S0022-3166(22)10281-6 15930466 · DOI · Paper page
- [26]Newgard CB An J Bain JR Muehlbauer MJ Stevens RD Lien LF Haqq AM Shah SH Arlotto M Slentz CA Rochon J Gallup D Ilkayeva O Wenner BR Yancy WS Eisenson H Musante G Surwit RS Millington DS Butler MD Svetkey LP A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance Cell Metab 2009 9 4 311 326 10.1016/j.cmet.2009.02.002 19356713 S1550-4131(09)00040-0 19356713 PMC3640280 · DOI · Paper page
- [27]Gancheva S Jelenik T Álvarez-Hernández E Roden M Interorgan metabolic crosstalk in human insulin resistance Physiol Rev 2018 98 3 1371 1415 10.1152/physrev.00015.2017 29767564 29767564 · DOI
- [28]Lee DY Kim JY Ahn E Hyeon JS Kim GH Park KJ Jung Y Lee YJ Son MK Kim SW Han SY Kim JH Roh GS Cha DR Hwang GS Kim WH Associations between local acidosis induced by renal LDHA and renal fibrosis and mitochondrial abnormalities in patients with diabetic kidney disease Transl Res 2022 249 88 109 10.1016/j.trsl.2022.06.015 35788054 S1931-5244(22)00149-9 35788054 · DOI
- [29]Sibley SD Hokanson JE Steffes MW Purnell JQ Marcovina SM Cleary PA Brunzell JD Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes Diabetes Care 1999 22 7 1165 1170 10.2337/diacare.22.7.1165 10388983 10388983 PMC2635089 · DOI
- [30]Mutter S Valo E Aittomäki V Nybo K Raivonen L Thorn LM Forsblom C Sandholm N Würtz P Groop PH Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes Diabetologia 2022 65 1 140 149 10.1007/s00125-021-05584-3 34686904 10.1007/s00125-021-05584-3 34686904 PMC8660744 · DOI
- [31]Shrier I Pang M Confounding, effect modification, and the odds ratio: common misinterpretations J Clin Epidemiol 2015 68 4 470 474 10.1016/j.jclinepi.2014.12.012 25662008 S0895-4356(15)00002-5 25662008 PMC4882164 · DOI
- [32]Williamson BD Gilbert PB Carone M Simon N Nonparametric variable importance assessment using machine learning techniques Biometrics 2021 77 1 9 22 10.1111/biom.13392 33043428 PMC7946807 · DOI
- [33]Wong TY Sabanayagam C Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence Ophthalmologica 2020 243 1 9 20 10.1159/000502387 31408872 000502387 31408872 · DOI
- [34]Seheult J Fitzpatrick G Boran G Lactic acidosis: an update Clin Chem Lab Med 2017 55 3 322 333 10.1515/cclm-2016-0438 27522622 /j/cclm.ahead-of-print/cclm-2016-0438/cclm-2016-0438.xml 27522622 · DOI
- [35]Bellomo R Bench-to-bedside review: lactate and the kidney Crit Care 2002 6 4 322 326 10.1186/cc1518 12225607 12225607 PMC137458 · DOI
- Authors
- He, F., Ng Yin Ling, C., Nusinovici, S., Cheng, C.-Y., Wong, T. Y., Li, J., & Sabanayagam, C.
- Affiliations
- National University of Singapore (SG)
- Singapore National Eye Center (SG)
- Corresponding author
- Sabanayagam, Charumathi
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2024-03-28
- Volume
- 26
- Pages
- e41065
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC11009843
- OpenAlex
- W4393257580
- Cited by
- 29
- References
- 40
- Citations by year
- 2026: 10 · 2025: 6 · 2024: 13
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic nephropathy, diabetic retinopathy, diabetic microvascular complications, circulating metabolites, biomarkers, machine learning prediction models, external validation, estimated glomerular filtration rate, risk factors, multi-ethnic Asian population, UK Biobank, HbA1c
- MeSH terms
- Adult, Aged, Cross-Sectional Studies, Diabetes Mellitus, Diabetic Retinopathy, Female, Humans, Insulin, Male, Middle Aged, Risk Factors, Tyrosine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review